Video Experimental Relacionado

Updated: Mar 22, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Terapias combinadas contra el cáncer con bloqueo del punto de control inmune: convergencia en la señalización de

Andy J Minn¹, E John Wherry²

¹Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

|April 9, 2016

Resumen

La combinación de terapias de bloqueo de puntos de control inmunológico con otros tratamientos puede mejorar la eficacia del tratamiento del cáncer. El interferón y las vías de señalización inmune innata influyen significativamente en la respuesta al tratamiento y la resistencia de manera compleja.

Área de la Ciencia:

Inmunología
En el campo de la oncología
Tratamiento del cáncer

Sus antecedentes:

El bloqueo del punto de control inmune (ICB) es una piedra angular de la terapia moderna del cáncer.
La mejora de la eficacia de ICB es crucial para superar la resistencia al tratamiento.
La interferona y las vías de señalización inmune innata juegan un papel complejo en la respuesta ICB.

Objetivo del estudio:

Explorar estrategias para mejorar la eficacia del bloqueo del punto de control inmune.
Investigar el papel del interferón y la señalización inmune innata en la respuesta y la resistencia a la ICB.

Principales métodos:

Enfoques de terapia combinada, incluida la ICB con otros agentes.
Análisis del interferón y las vías de señalización inmunológica innata en las células inmunes y tumorales.

Principales resultados:

La combinación de agentes ICB entre sí o con otras terapias puede mejorar la eficacia.
El interferón y las vías de señalización inmune innata son determinantes clave de la respuesta y la resistencia.
Estas vías presentan efectos complejos y a veces paradójicos en los resultados del tratamiento.

Conclusiones:

Las terapias combinadas representan una estrategia prometedora para mejorar la eficacia de la ICB.
Comprender las funciones intrincadas del interferón y la inmunidad innata es vital para optimizar el tratamiento del cáncer.

Más Videos Relacionados

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Videos de Conceptos Relacionados

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Targeted Cancer Therapies

Targeted Cancer Therapies

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...